title: Intranasal drug delivery. Potential advantages and limitations from a clinical pharmacokinetic perspective.
authors.affiliation: Istituto Scientifico San Raffaele, Cattedra di Clinica Medica, Università di Milano, Italy.
authors.forename: A E
authors.initials: AE
authors.lastname: Pontiroli
authors.forename: A
authors.initials: A
authors.lastname: Calderara
authors.forename: G
authors.initials: G
authors.lastname: Pozza
mesh_terms: D000281:Administration, Intranasal; D002116:Calcitonin / Q000008:administration & dosage; D003346:Corticotropin-Releasing Hormone / Q000008:administration & dosage; D005934:Glucagon / Q000008:administration & dosage; D013007:Growth Hormone-Releasing Hormone / Q000008:administration & dosage; D006801:Humans; D007328:Insulin / Q000008:administration & dosage; D010455:Peptides / Q000008:administration & dosage* / Q000493:pharmacokinetics
chemical_list: D007328:Insulin; D010455:Peptides; D002116:Calcitonin; D005934:Glucagon; D003346:Corticotropin-Releasing Hormone; D013007:Growth Hormone-Releasing Hormone